How to tailor an eye examination and what technology to consider.

Physicians ask the right questions and take an aggressive approach to treatment.

Clinicians may have difficulty in making a diagnosis.

You may be wondering: What is all this hype about geographic atrophy (GA)? If you are, let us look at the enigma.

According to Regeneron, the approval was based on data in the PULSAR and PHOTON trials, in which the drug demonstrated clinically equivalent vision gains to aflibercept Injection 2 mg that were maintained with fewer injections.

Catch up on what happened in optometry during the week of August 14-August 18.

Fuensanta A. Vera-Diaz, OD, PhD, FAAO, Director of Research and Associate Professor of Optometry at the New England College of Optometry (NECO) repersented AAO at the first meeting of the Committee on Focus on Myopia.

Managing dry eye disease often is key to patient comfort.

According to Regeneron, visual gains and safety of aflibercept 8 mg remained consistent with the established profile of aflibercept 2 mg injection.

Being a selfless provider will earn you trust and loyalty.

Oculis Holding AG announced, if approved, OCS-01 has the potential to become a new standard of care as the first once-daily, topical, preservative-free corticosteroid for treating inflammation and pain following ocular surgery.

Evaluating images for quality, artifacts, and segmentation errors.

Catch up on what happened in optometry during the week of August 7-August 11.

An industrial engineer and entrepreneur, George Glady was a founder of Euclid Systems Corp. and developed the concept of the Ortho-K contact lenses.

The investigators explored the effects of the following covariates on development of AMD: sex, ethnicity, smoking history, fluoxetine use, obesity, diabetes mellitus, and hypertension.

This new technology incorporates a torque management system and wavefront-based technology.

Doctors should consider a few key points before writing a prescription.

Arshad M. Khanani, MD, MA, FASRS, sat down with Optometry Times to discuss the recent FDA approval of avacincaptad pegol intravitreal solution for treatment of geographic atrophy.

The AOA joins several industry leaders in taking the pledge to increase opportunities for Black optometrists and students